Aurobindo Co-Founder Hit With $3m Fine For Insider Trading
Indian stock market regulator SEBI has taken action over deals involving Pfizer
Executive Summary
Indian stock market regulator SEBI has slapped the billionaire founder of Aurobindo Pharma, along with other promoters of the company, with a more than $3m fine for allegedly violating insider trading norms over a string of licensing agreements with multinational Pfizer.